145 related articles for article (PubMed ID: 19388879)
21. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
22. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma.
Zhou B; Yan Z; Liu R; Shi P; Qian S; Qu X; Zhu L; Zhang W; Wang J
Radiology; 2016 Aug; 280(2):630-9. PubMed ID: 26885681
[TBL] [Abstract][Full Text] [Related]
23. Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression.
Wu GL; Zhang L; Li TY; Chen J; Yu GY; Li JP
Chin J Integr Med; 2010 Apr; 16(2):109-13. PubMed ID: 20473734
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
[TBL] [Abstract][Full Text] [Related]
25. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
[TBL] [Abstract][Full Text] [Related]
26. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Huo YR; Eslick GD
JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
[TBL] [Abstract][Full Text] [Related]
27. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
28. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study.
Tang CW; Zhu M; Feng WM; Bao Y; Zheng YY
Drug Des Devel Ther; 2016; 10():2461-6. PubMed ID: 27536066
[TBL] [Abstract][Full Text] [Related]
29. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
[TBL] [Abstract][Full Text] [Related]
30. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial.
Zhai XF; Chen Z; Li B; Shen F; Fan J; Zhou WP; Yang YK; Xu J; Qin X; Li LQ; Ling CQ
J Integr Med; 2013 Mar; 11(2):90-100. PubMed ID: 23506690
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines].
Chen XX; Zhang B; Zhang YQ; Hung GX; Chen MS; Guo RP; Lin XJ; Hu PL; Qiu HJ; Xu BP
Ai Zheng; 2002 May; 21(5):547-9. PubMed ID: 12452052
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Meng MB; Wen QL; Cui YL; She B; Zhang RM
Explore (NY); 2011; 7(1):37-43. PubMed ID: 21194671
[TBL] [Abstract][Full Text] [Related]
34. [Network Meta-analysis of oral Chinese patent medicine for adjuvant treatment of primary liver cancer].
Zhang RR; Shao MY; Fu Y; Zhao RX; Wang JW; Li M; Zhao YX; Shao FL
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2333-2343. PubMed ID: 34047138
[TBL] [Abstract][Full Text] [Related]
35. [Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin].
Kawamura Y; Ikeda K; Kumada H
Gan To Kagaku Ryoho; 2010 Mar; 37(3):402-7. PubMed ID: 20332675
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.
Endo K; Kuroda H; Oikawa T; Okada Y; Fujiwara Y; Abe T; Sato H; Sawara K; Takikawa Y
Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
[TBL] [Abstract][Full Text] [Related]
39. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
Ramsey DE; Geschwind JF
Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
[TBL] [Abstract][Full Text] [Related]
40. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
Oliveri RS; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2011 Mar; (3):CD004787. PubMed ID: 21412886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
